Program
Speakers
|
The role of perioperative systemic therapy in patients with upper tract urothelial carcinoma
Alison Birtle, Prof. Dr. med., Lancashire Teaching Hospitals, Lancs, UK |
|---|---|
|
Current standards and the role of robotic surgery for the treatment of upper tract urothelial cancer
Rajesh Nair, Dr. med., Guy’s and St. Thomas’ Hospital, London, UK
|
|
Improving robotic minimal invasive surgery in urological malignancies
Henk van der Poel, Prof. Dr. med., Netherlands Cancer Institute, Amsterdam, NL |
|
Game Changing Research in Urology
Laurence Klotz, Prof. Dr. med., University of Toronto, Toronto, Canada |
| Discussion “Tumour genomic profiling for urogenital malignancies: Benefit or Non-sense?” | |
|
Pro: Aurelius Omlin, PD Dr. med., Kantonsspital St. Gallen, CH |
|
Con: Jörg Beyer, Prof. Dr. med., Inselspital Bern, CH |
| Discussion “Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer: Justified or Not?” | |
|
Pro: Jochen Walz, Prof. Dr. med., Institut Paoli-Calmettes, Marseille, France |
|
Con: Andrew Vickers, Prof. Dr. med., Memorial Sloan Kettering Cancer Center, New York, USA |